AllianceBernstein’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $180K | Buy |
62,380
+29,320
| +89% | +$84.7K | ﹤0.01% | 3076 |
|
|
2025
Q1 | $71.1K | Hold |
33,060
| – | – | ﹤0.01% | 3098 |
|
|
2024
Q4 | $128K | Hold |
33,060
| – | – | ﹤0.01% | 3100 |
|
|
2024
Q3 | $217K | Buy |
33,060
+5,270
| +19% | +$34.5K | ﹤0.01% | 3017 |
|
|
2024
Q2 | $201K | Buy |
+27,790
| New | +$201K | ﹤0.01% | 3035 |
|
|
2019
Q2 | – | Sell |
-875
| Closed | -$29K | – | 3172 |
|
|
2019
Q1 | $29K | Hold |
875
| – | – | ﹤0.01% | 3087 |
|
|
2018
Q4 | $52K | Buy |
+875
| New | +$52K | ﹤0.01% | 3047 |
|
|
2017
Q2 | – | Sell |
-925
| Closed | -$52K | – | 3140 |
|
|
2017
Q1 | $52K | Hold |
925
| – | – | ﹤0.01% | 2948 |
|
|
2016
Q4 | $35K | Hold |
925
| – | – | ﹤0.01% | 2977 |
|
|
2016
Q3 | $37K | Sell |
925
-667
| -42% | -$26.7K | ﹤0.01% | 2952 |
|
|
2016
Q2 | $114K | Buy |
+1,592
| New | +$114K | ﹤0.01% | 2889 |
|
|
2016
Q1 | – | Sell |
-1,295
| Closed | -$98K | – | 2913 |
|
|
2015
Q4 | $98K | Sell |
1,295
-342
| -21% | -$25.9K | ﹤0.01% | 2841 |
|
|
2015
Q3 | $627K | Sell |
1,637
-171
| -9% | -$65.5K | ﹤0.01% | 2392 |
|
|
2015
Q2 | $751K | Buy |
1,808
+1,133
| +168% | +$471K | ﹤0.01% | 2414 |
|
|
2015
Q1 | $321K | Buy |
+675
| New | +$321K | ﹤0.01% | 2642 |
|